Genome instability of ageing stem cells-Induction and defence mechanisms

Ageing Research Reviews

Volumn 23, Issue PA, 2015, Pages 29-36

  Burkhalter, Martin D ^a   Rudolph, K Lenhard ^a   Sperka, Tobias ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

Ageing; Cancer; Checkpoint; DNA repair; Genome maintenance; Stem cell

Indexed keywords

APOPTOSIS; ARTICLE; CELL AGING; CELL DAMAGE; CELL DIFFERENTIATION; CELL RENEWAL; CELL SURVIVAL; DNA DAMAGE; DNA DAMAGE CHECKPOINT; DNA END JOINING REPAIR; DNA REPAIR; DNA REPLICATION; DNA STRAND; DNA STRAND BREAKAGE; GENOME; GENOMIC INSTABILITY; GERMLINE MUTATION; HUMAN; MITOCHONDRIAL RESPIRATION; NONHUMAN; SENESCENCE; STEM CELL; TELOMERE; TELOMERE SHORTENING; ANIMAL; GENETICS; MUTATION; PHYSIOLOGY;

MAMMALIA;

ANIMALS; CELL AGING; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; MUTATION; STEM CELLS;

EID: 84931573069     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2015.01.004     Document Type: Review

References (98)

1. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 2003, 102:517-520. (in vivo & in vitro evidence).
2. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
3. Attema J.L., Pronk C.J., Norddahl G.L., Nygren J.M., Bryder D. Hematopoietic stem cell ageing is uncoupled from p16 INK4A-mediated senescence. Oncogene 2009, 28:2238-2243. (in vivo evidence).
4. Avagyan S., Churchill M., Yamamoto K., Crowe J.L., Li C., Lee B.J., Zheng T., Mukherjee S., Zha S. Hematopoietic stem cell dysfunction underlies the progressive lymphocytopenia in XLF/cernunnos deficiency. Blood 2014, 124:1622-1625. (in vivo evidence).
5. Beerman I., Seita J., Inlay M.A., Weissman I.L., Rossi D.J. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell 2014, 15:37-50. (in vivo & in vitro evidence).
6. Begus-Nahrmann Y., Lechel A., Obenauf A.C., Nalapareddy K., Peit E., Hoffmann E., Schlaudraff F., Liss B., Schirmacher P., Kestler H., Danenberg E., Barker N., Clevers H., Speicher M.R., Rudolph K.L. p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat. Genet. 2009, 41:1138-1143. (in vivo & in vitro evidence).
7. Betermier M., Bertrand P., Lopez B.S. Is non-homologous end-joining really an inherently error-prone process?. PLoS Genet. 2014, 10:e1004086.
8. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
9. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277:831-834.
10. Burtner C.R., Kennedy B.K. Progeria syndromes and ageing: what is the connection? Nature reviews. Mol. Cell. Biol. 2010, 11:567-578.
11. Busque L., Patel J.P., Figueroa M.E., Vasanthakumar A., Provost S., Hamilou Z., Mollica L., Li J., Viale A., Heguy A., Hassimi M., Socci N., Bhatt P.K., Gonen M., Mason C.E., Melnick A., Godley L.A., Brennan C.W., Abdel-Wahab O., Levine R.L. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat. Genet. 2012, 44:1179-1181.
12. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003, 361:393-395.
13. Ceccaldi R., Parmar K., Mouly E., Delord M., Kim J.M., Regairaz M., Pla M., Vasquez N., Zhang Q.S., Pondarre C., Peffault de Latour R., Gluckman E., Cavazzana-Calvo M., Leblanc T., Larghero J., Grompe M., Socie G., D'Andrea A.D., Soulier J. Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell 2012, 11:36-49. (in vivo & in vitro evidence).
14. Chang S., Multani A.S., Cabrera N.G., Naylor M.L., Laud P., Lombard D., Pathak S., Guarente L., DePinho R.A. Essential role of limiting telomeres in the pathogenesis of Werner syndrome. Nat. Genet. 2004, 36:877-882.
15. Chen C., Liu Y., Liu R., Ikenoue T., Guan K.L., Liu Y., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205:2397-2408. (in vivo evidence).
16. Cheung T.H., Rando T.A. Molecular regulation of stem cell quiescence. Nat. Rev. Mol. Cell Biol. 2013, 14:329-340.
17. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999, 97:527-538.
18. Chiu C.P., Dragowska W., Kim N.W., Vaziri H., Yui J., Thomas T.E., Harley C.B., Lansdorp P.M. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 1996, 14:239-248.
19. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., Lee H.W., von Zglinicki T., Ganser A., Schirmacher P., Nakauchi H., Rudolph K.L. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 2007, 39:99-105. (in vivo evidence).
20. Chow T.T., Zhao Y., Mak S.S., Shay J.W., Wright W.E. Early and late steps in telomere overhang processing in normal human cells: the position of the final RNA primer drives telomere shortening. Genes Dev. 2012, 26:1167-1178.
21. Chu W.K., Hickson I.D. RecQ helicases: multifunctional genome caretakers. Nat. Rev. Cancer 2009, 9:644-654.
22. Conboy M.J., Karasov A.O., Rando T.A. High incidence of non-random template strand segregation and asymmetric fate determination in dividing stem cells and their progeny. PLoS Biol. 2007, 5:e102. (in vivo & in vitro evidence).
23. Corces-Zimmerman M.R., Hong W.J., Weissman I.L., Medeiros B.C., Majeti R. Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:2548-2553.
24. Crabbe L., Verdun R.E., Haggblom C.I., Karlseder J. Defective telomere lagging strand synthesis in cells lacking WRN helicase activity. Science 2004, 306:1951-1953.
25. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426:194-198.
26. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326:948-952.
27. DeGregori J. Challenging the axiom: does the occurrence of oncogenic mutations truly limit cancer development with age?. Oncogene 2013, 32:1869-1875.
28. Didier N., Hourde C., Amthor H., Marazzi G., Sassoon D. Loss of a single allele for Ku80 leads to progenitor dysfunction and accelerated aging in skeletal muscle. EMBO Mol. Med. 2012, 4:910-923. (in vivo & in vitro evidence).
29. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:9363-9367.
30. Du X., Shen J., Kugan N., Furth E.E., Lombard D.B., Cheung C., Pak S., Luo G., Pignolo R.J., DePinho R.A., Guarente L., Johnson F.B. Telomere shortening exposes functions for the mouse Werner and Bloom syndrome genes. Mol. Cell. Biol. 2004, 24:8437-8446.
31. Escobar M., Nicolas P., Sangar F., Laurent-Chabalier S., Clair P., Joubert D., Jay P., Legraverend C. Intestinal epithelial stem cells do not protect their genome by asymmetric chromosome segregation. Nat. Commun. 2011, 2:258. (in vivo evidence).
32. Feng Z., Hu W., Teresky A.K., Hernando E., Cordon-Cardo C., Levine A.J. Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16633-16638.
33. Flach J., Bakker S.T., Mohrin M., Conroy P.C., Pietras E.M., Reynaud D., Alvarez S., Diolaiti M.E., Ugarte F., Forsberg E.C., Le Beau M.M., Stohr B.A., Mendez J., Morrison C.G., Passegue E. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature 2014, 512:198-202. (in vivo & in vitro evidence).
34. Fumagalli M., Rossiello F., Clerici M., Barozzi S., Cittaro D., Kaplunov J.M., Bucci G., Dobreva M., Matti V., Beausejour C.M., Herbig U., Longhese M.P., d'Adda di Fagagna F. Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation. Nat. Cell Biol. 2012, 14:355-365.
35. Gan B., Hu J., Jiang S., Liu Y., Sahin E., Zhuang L., Fletcher-Sananikone E., Colla S., Wang Y.A., Chin L., Depinho R.A. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 2010, 468:701-704. (in vivo evidence).
36. Garaycoechea J.I., Crossan G.P., Langevin F., Daly M., Arends M.J., Patel K.J. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 2012, 489:571-575. (in vivo evidence).
37. Goriely A., Hansen R.M., Taylor I.B., Olesen I.A., Jacobsen G.K., McGowan S.J., Pfeifer S.P., McVean G.A., Rajpert-De Meyts E., Wilkie A.O. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat. Genet. 2009, 41:1247-1252.
38. Goriely A., McVean G.A., Rojmyr M., Ingemarsson B., Wilkie A.O. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 2003, 301:643-646.
39. Greenow K.R., Clarke A.R., Jones R.H. Chk1 deficiency in the mouse small intestine results in p53-independent crypt death and subsequent intestinal compensation. Oncogene 2009, 28:1443-1453. (in vivo evidence).
40. Hara E., Tsurui H., Shinozaki A., Nakada S., Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 1991, 179:528-534.
41. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868.
42. Heidinger B.J., Blount J.D., Boner W., Griffiths K., Metcalfe N.B., Monaghan P. Telomere length in early life predicts lifespan. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1743-1748.
43. Henriques C.M., Carneiro M.C., Tenente I.M., Jacinto A., Ferreira M.G. Telomerase is required for zebrafish lifespan. PLoS Genet. 2013, 9:e1003214.
44. Herbig U., Ferreira M., Condel L., Carey D., Sedivy J.M. Cellular senescence in aging primates. Science 2006, 311:1257.
45. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708. (in vivo evidence).
46. Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361:1475-1485.
47. Hua G., Thin T.H., Feldman R., Haimovitz-Friedman A., Clevers H., Fuks Z., Kolesnick R. Crypt base columnar stem cells in small intestines of mice are radioresistant. Gastroenterology 2012, 143:1266-1276. (in vivo evidence).
48. Inomata K., Aoto T., Binh N.T., Okamoto N., Tanimura S., Wakayama T., Iseki S., Hara E., Masunaga T., Shimizu H., Nishimura E.K. Genotoxic stress abrogates renewal of melanocyte stem cells by triggering their differentiation. Cell 2009, 137:1088-1099. (in vivo evidence).
49. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002. (in vivo & in vitro evidence).
50. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 2006, 12:446-451. (in vivo & in vitro evidence).
51. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
52. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006, 443:421-426. (in vivo evidence).
53. Jiang H., Ju Z., Rudolph K.L. Telomere shortening and ageing. Z. Gerontol. Geriatr. 2007, 40:314-324.
54. Kiel M.J., He S., Ashkenazi R., Gentry S.N., Teta M., Kushner J.A., Jackson T.L., Morrison S.J. Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU. Nature 2007, 449:238-242. (in vivo & in vitro evidence).
55. Lessel D., Vaz B., Halder S., Lockhart P.J., Marinovic-Terzic I., Lopez-Mosqueda J., Philipp M., Sim J.C., Smith K.R., Oehler J., Cabrera E., Freire R., Pope K., Nahid A., Norris F., Leventer R.J., Delatycki M.B., Barbi G., von Ameln S., Hogel J., Degoricija M., Fertig R., Burkhalter M.D., Hofmann K., Thiele H., Altmuller J., Nurnberg G., Nurnberg P., Bahlo M., Martin G.M., Aalfs C.M., Oshima J., Terzic J., Amor D.J., Dikic I., Ramadan K., Kubisch C. Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features. Nat. Genet. 2014, 46:1239-1244.
56. Lundblad V. Telomere end processing: unexpected complexity at the end game. Genes Dev. 2012, 26:1123-1127.
57. Martin K., Kirkwood T.B., Potten C.S. Age changes in stem cells of murine small intestinal crypts. Exp. Cell. Res. 1998, 241:316-323. (in vivo evidence).
58. Maser R.S., Wong K.K., Sahin E., Xia H., Naylor M., Hedberg H.M., Artandi S.E., DePinho R.A. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell. Biol. 2007, 27:2253-2265.
59. Miyamoto K., Araki K.Y., Naka K., Arai F., Takubo K., Yamazaki S., Matsuoka S., Miyamoto T., Ito K., Ohmura M., Chen C., Hosokawa K., Nakauchi H., Nakayama K., Nakayama K.I., Harada M., Motoyama N., Suda T., Hirao A. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1:101-112. (in vivo & in vitro evidence).
60. Mohrin M., Bourke E., Alexander D., Warr M.R., Barry-Holson K., Le Beau M.M., Morrison C.G., Passegue E. Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010, 7:174-185. (in vivo & in vitro evidence).
61. Nijnik A., Woodbine L., Marchetti C., Dawson S., Lambe T., Liu C., Rodrigues N.P., Crockford T.L., Cabuy E., Vindigni A., Enver T., Bell J.I., Slijepcevic P., Goodnow C.C., Jeggo P.A., Cornall R.J. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007, 447:686-690. (in vivo evidence).
62. Noda S., Ichikawa H., Miyoshi H. Hematopoietic stem cell aging is associated with functional decline and delayed cell cycle progression. Biochem. Biophys. Res. Commun. 2009, 383:210-215. (in vivo evidence).
63. Nombela-Arrieta C., Pivarnik G., Winkel B., Canty K.J., Harley B., Mahoney J.E., Park S.Y., Lu J., Protopopov A., Silberstein L.E. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat. Cell Biol. 2013, 15:533-543. (in vivo evidence).
64. Potten C.S., Owen G., Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J. Cell Sci. 2002, 115:2381-2388. (in vivo evidence).
65. Rai R., Zheng H., He H., Luo Y., Multani A., Carpenter P.B., Chang S. The function of classical and alternative non-homologous end-joining pathways in the fusion of dysfunctional telomeres. EMBO J. 2010, 29:2598-2610.
66. Rossi D.J., Bryder D., Seita J., Nussenzweig A., Hoeijmakers J., Weissman I.L. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007, 447:725-729. (in vivo & in vitro evidence).
67. Rossi D.J., Seita J., Czechowicz A., Bhattacharya D., Bryder D., Weissman I.L. Hematopoietic stem cell quiescence attenuates DNA damage response and permits DNA damage accumulation during aging. Cell Cycle 2007, 6:2371-2376. (in vivo evidence).
68. Rübe C.E., Fricke A., Widmann T.A., Furst T., Madry H., Pfreundschuh M., Rübe C. Accumulation of DNA damage in hematopoietic stem and progenitor cells during human aging. PLoS ONE 2011, 6:e17487. (in vivo & in vitro evidence).
69. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999, 96:701-712.
70. Ruzankina Y., Pinzon-Guzman C., Asare A., Ong T., Pontano L., Cotsarelis G., Zediak V.P., Velez M., Bhandoola A., Brown E.J. Deletion of the developmentally essential gene ATR in adult mice leads to age-related phenotypes and stem cell loss. Cell Stem Cell 2007, 1:113-126. (in vivo evidence).
71. Ruzankina Y., Schoppy D.W., Asare A., Clark C.E., Vonderheide R.H., Brown E.J. Tissue regenerative delays and synthetic lethality in adult mice after combined deletion of Atr and Trp53. Nat. Genet. 2009, 41:1144-1149. (in vivo evidence).
72. Salomons H.M., Mulder G.A., van de Zande L., Haussmann M.F., Linskens M.H., Verhulst S. Telomere shortening and survival in free-living corvids. Proc. Biol. Sci. 2009, 276:3157-3165.
73. Santos M.A., Faryabi R.B., Ergen A.V., Day A.M., Malhowski A., Canela A., Onozawa M., Lee J.E., Callen E., Gutierrez-Martinez P., Chen H.T., Wong N., Finkel N., Deshpande A., Sharrow S., Rossi D.J., Ito K., Ge K., Aplan P.D., Armstrong S.A., Nussenzweig A. DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier. Nature 2014, 514:107-111. (in vivo evidence).
74. Schaetzlein S., Kodandaramireddy N.R., Ju Z., Lechel A., Stepczynska A., Lilli D.R., Clark A.B., Rudolph C., Kuhnel F., Wei K., Schlegelberger B., Schirmacher P., Kunkel T.A., Greenberg R.A., Edelmann W., Rudolph K.L. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 2007, 130:863-877. (in vivo evidence).
75. Schepers A.G., Vries R., van den Born M., van de Wetering M., Clevers H. Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J. 2011, 30:1104-1109. (in vivo & in vitro evidence).
76. Shinin V., Gayraud-Morel B., Gomes D., Tajbakhsh S. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat. Cell Biol. 2006, 8:677-687. (in vivo & in vitro evidence).
77. Sotiropoulou P.A., Candi A., Mascre G., De Clercq S., Youssef K.K., Lapouge G., Dahl E., Semeraro C., Denecker G., Marine J.C., Blanpain C. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat. Cell Biol. 2010, 12:572-582. (in vivo & in vitro evidence).
78. Sousa-Victor P., Gutarra S., Garcia-Prat L., Rodriguez-Ubreva J., Ortet L., Ruiz-Bonilla V., Jardi M., Ballestar E., Gonzalez S., Serrano A.L., Perdiguero E., Munoz-Canoves P. Geriatric muscle stem cells switch reversible quiescence into senescence. Nature 2014, 506:316-321. (in vivo & in vitro evidence).
79. Sperka T., Song Z., Morita Y., Nalapareddy K., Guachalla L.M., Lechel A., Begus-Nahrmann Y., Burkhalter M.D., Mach M., Schlaudraff F., Liss B., Ju Z., Speicher M.R., Rudolph K.L. Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction. Nat. Cell Biol. 2012, 14:73-79. (in vivo & in vitro evidence).
80. Steinhauser M.L., Bailey A.P., Senyo S.E., Guillermier C., Perlstein T.S., Gould A.P., Lee R.T., Lechene C.P. Multi-isotope imaging mass spectrometry quantifies stem cell division and metabolism. Nature 2012, 481:516-519. (in vivo evidence).
81. Sun J., Ramos A., Chapman B., Johnnidis J.B., Le L., Ho Y.J., Klein A., Hofmann O., Camargo F.D. Clonal dynamics of native haematopoiesis. Nature 2014, 514:322-327. (in vivo evidence).
82. Takubo K., Nagamatsu G., Kobayashi C.I., Nakamura-Ishizu A., Kobayashi H., Ikeda E., Goda N., Rahimi Y., Johnson R.S., Soga T., Hirao A., Suematsu M., Suda T. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell 2013, 12:49-61. (in vivo & in vitro evidence).
83. Tothova Z., Kollipara R., Huntly B.J., Lee B.H., Castrillon D.H., Cullen D.E., McDowell E.P., Lazo-Kallanian S., Williams I.R., Sears C., Armstrong S.A., Passegue E., DePinho R.A., Gilliland D.G. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339. (in vivo evidence).
84. Vahidi Ferdousi L., Rocheteau P., Chayot R., Montagne B., Chaker Z., Flamant P., Tajbakhsh S., Ricchetti M. More efficient repair of DNA double-strand breaks in skeletal muscle stem cells compared to their committed progeny. Stem Cell Res. 2014, 13:492-507. (in vitro evidence).
85. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:9857-9860. (in vitro evidence).
86. Visvader J.E. Cells of origin in cancer. Nature 2011, 469:314-322.
87. Wang C., Sinha Hikim A.P., Lue Y.H., Leung A., Baravarian S., Swerdloff R.S. Reproductive aging in the Brown Norway rat is characterized by accelerated germ cell apoptosis and is not altered by luteinizing hormone replacement. J. Androl. 1999, 20:509-518. (in vivo evidence).
88. Wang J., Sun Q., Morita Y., Jiang H., Gross A., Lechel A., Hildner K., Guachalla L.M., Gompf A., Hartmann D., Schambach A., Wuestefeld T., Dauch D., Schrezenmeier H., Hofmann W.K., Nakauchi H., Ju Z., Kestler H.A., Zender L., Rudolph K.L. A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage. Cell 2012, 148:1001-1014. (in vivo evidence).
89. Wang J., Lu X., Sakk V., Klein C.A., Rudolph K.L. Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood 2014, 124:3237-3240. (in vivo & in vitro evidence).
90. Waters C.A., Strande N.T., Pryor J.M., Strom C.N., Mieczkowski P., Burkhalter M.D., Oh S., Qaqish B.F., Moore D.T., Hendrickson E.A., Ramsden D.A. The fidelity of the ligation step determines how ends are resolved during nonhomologous end joining. Nat. Commun. 2014, 5:4286.
91. Welch J.S., Ley T.J., Link D.C., Miller C.A., Larson D.E., Koboldt D.C., Wartman L.D., Lamprecht T.L., Liu F., Xia J., Kandoth C., Fulton R.S., McLellan M.D., Dooling D.J., Wallis J.W., Chen K., Harris C.C., Schmidt H.K., Kalicki-Veizer J.M., Lu C., Zhang Q., Lin L., O'Laughlin M.D., McMichael J.F., Delehaunty K.D., Fulton L.A., Magrini V.J., McGrath S.D., Demeter R.T., Vickery T.L., Hundal J., Cook L.L., Swift G.W., Reed J.P., Alldredge P.A., Wylie T.N., Walker J.R., Watson M.A., Heath S.E., Shannon W.D., Varghese N., Nagarajan R., Payton J.E., Baty J.D., Kulkarni S., Klco J.M., Tomasson M.H., Westervelt P., Walter M.J., Graubert T.A., DiPersio J.F., Ding L., Mardis E.R., Wilson R.K. The origin and evolution of mutations in acute myeloid leukemia. Cell 2012, 150:264-278.
92. Wilson A., Laurenti E., Oser G., van der Wath R.C., Blanco-Bose W., Jaworski M., Offner S., Dunant C.F., Eshkind L., Bockamp E., Lio P., Macdonald H.R., Trumpp A. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008, 135:1118-1129. (in vivo evidence).
93. Wright W.E., Piatyszek M.A., Rainey W.E., Byrd W., Shay J.W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 1996, 18:173-179.
94. Xie M., Lu C., Wang J., McLellan M.D., Johnson K.J., Wendl M.C., McMichael J.F., Schmidt H.K., Yellapantula V., Miller C.A., Ozenberger B.A., Welch J.S., Link D.C., Walter M.J., Mardis E.R., Dipersio J.F., Chen F., Wilson R.K., Ley T.J., Ding L. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 2014, 20(12):1472-1478.
95. Yalcin S., Zhang X., Luciano J.P., Mungamuri S.K., Marinkovic D., Vercherat C., Sarkar A., Grisotto M., Taneja R., Ghaffari S. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J. Biol. Chem. 2008, 283:25692-25705. (in vivo & in vitro evidence).
96. Yu W.M., Liu X., Shen J., Jovanovic O., Pohl E.E., Gerson S.L., Finkel T., Broxmeyer H.E., Qu C.K. Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell 2013, 12:62-74. (in vivo evidence).
97. Zeman M.K., Cimprich K.A. Causes and consequences of replication stress. Nat. Cell Biol. 2014, 16:2-9.
98. Zhang S., Yajima H., Huynh H., Zheng J., Callen E., Chen H.T., Wong N., Bunting S., Lin Y.F., Li M., Lee K.J., Story M., Gapud E., Sleckman B.P., Nussenzweig A., Zhang C.C., Chen D.J., Chen B.P. Congenital bone marrow failure in DNA-PKcs mutant mice associated with deficiencies in DNA repair. J. Cell. Biol. 2011, 193:295-305. (in vivo evidence).